Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Ligand Pharmaceuticals Profit Margin 2006-2018 | LGND

Current and historical gross margin, operating margin and net profit margin for Ligand Pharmaceuticals (LGND) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Ligand Pharmaceuticals net profit margin as of December 31, 2018 is 57%.
Ligand Pharmaceuticals Annual Profit Margins
Ligand Pharmaceuticals Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.569B $0.251B
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Biogen (BIIB) United States $65.478B 12.69
Celgene (CELG) United States $63.576B 11.78
Vertex Pharmaceuticals (VRTX) United States $48.081B 64.41
Regeneron Pharmaceuticals (REGN) United States $46.330B 21.52
Illumina (ILMN) United States $44.074B 52.42
Alexion Pharmaceuticals (ALXN) United States $28.921B 17.92
Incyte (INCY) United States $18.013B 168.30
BioMarin Pharmaceutical (BMRN) United States $16.736B 0.00
Seattle Genetics (SGEN) United States $11.477B 0.00
Exact Sciences (EXAS) United States $10.883B 0.00
Sarepta Therapeutics (SRPT) United States $9.252B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.876B 0.00
QIAGEN (QGEN) Netherlands $8.819B 28.84
BeiGene (BGNE) Cayman Islands $7.856B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bluebird Bio (BLUE) United States $7.495B 0.00
Bio-Techne Corp (TECH) United States $7.237B 48.76
Moderna (MRNA) United States $7.053B 0.00
Exelixis (EXEL) United States $6.655B 15.57
Amarin (AMRN) Ireland $5.703B 0.00
Galapagos (GLPG) Belgium $5.283B 0.00
Alkermes (ALKS) Ireland $5.078B 0.00
Array BioPharma (ARRY) United States $5.047B 0.00
Guardant Health (GH) United States $4.379B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.077B 0.00
Horizon Pharma Public (HZNP) Ireland $3.884B 15.98
Allogene Therapeutics (ALLO) United States $3.795B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.458B 0.00
Emergent Biosolutions (EBS) United States $3.371B 28.40
Blueprint Medicines (BPMC) United States $3.339B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.286B 0.00
Ascendis Pharma (ASND) Denmark $3.087B 0.00
Genomic Health (GHDX) United States $3.011B 101.63
ACADIA Pharmaceuticals (ACAD) United States $2.908B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.865B 0.00
Global Blood Therapeutics (GBT) United States $2.722B 0.00
Immunomedics (IMMU) United States $2.710B 0.00
China Biologic Products (CBPO) China $2.701B 19.23
Repligen (RGEN) United States $2.640B 82.45
Reata Pharmaceuticals (RETA) United States $2.566B 0.00
Mirati Therapeutics (MRTX) United States $2.496B 0.00
Akcea Therapeutics (AKCA) United States $2.472B 0.00
Arena Pharmaceuticals (ARNA) United States $2.466B 0.00
Halozyme Therapeutics (HALO) United States $2.463B 54.97
Myriad Genetics (MYGN) United States $2.305B 23.48
Amicus Therapeutics (FOLD) United States $2.162B 0.00
Insmed (INSM) United States $2.087B 0.00
Spark Therapeutics (ONCE) United States $1.992B 0.00
Denali Therapeutics (DNLI) United States $1.991B 0.00
Acceleron Pharma (XLRN) United States $1.961B 0.00
Atara Biotherapeutics (ATRA) United States $1.846B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.830B 0.00
Medicines (MDCO) United States $1.830B 0.00
AnaptysBio (ANAB) United States $1.828B 0.00
REGENXBIO (RGNX) United States $1.725B 23.14
MyoKardia (MYOK) United States $1.719B 0.00
NeoGenomics (NEO) United States $1.649B 135.69
CRISPR Therapeutics AG (CRSP) Switzerland $1.636B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.630B 0.00
Myovant Sciences (MYOV) United Kingdom $1.509B 0.00
Innoviva (INVA) United States $1.497B 4.13
Allakos (ALLK) United States $1.468B 0.00
Aimmune Therapeutics (AIMT) United States $1.422B 0.00
UniQure (QURE) Netherlands $1.396B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.380B 0.00
ALECTOR INC (ALEC) United States $1.352B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.347B 0.00
Clovis Oncology (CLVS) United States $1.344B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.282B 0.00
Lion Biotechnologies (IOVA) United States $1.272B 0.00
Cambrex (CBM) United States $1.266B 13.65
GOSSAMER BIO (GOSS) United States $1.221B 0.00
Codexis (CDXS) United States $1.184B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.172B 0.00
WAVE Life Sciences (WVE) Singapore $1.108B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.107B 44.92
Rubius Therapeutics (RUBY) United States $1.104B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.092B 0.00
Audentes Therapeutics (BOLD) United States $1.055B 0.00
Puma Biotechnology (PBYI) United States $1.055B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.034B 0.00
Epizyme (EPZM) United States $1.020B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.978B 0.00
Editas Medicine (EDIT) United States $0.960B 0.00
Fate Therapeutics (FATE) United States $0.960B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.958B 0.00
Coherus BioSciences (CHRS) United States $0.948B 0.00
Sangamo Therapeutics (SGMO) United States $0.897B 0.00
Retrophin (RTRX) United States $0.889B 0.00
Athenex (ATNX) United States $0.846B 0.00
Vericel (VCEL) United States $0.845B 0.00
CytomX Therapeutics (CTMX) United States $0.829B 0.00
Novavax (NVAX) United States $0.815B 0.00
G1 THERAPEUTICS (GTHX) United States $0.781B 0.00
Apellis Pharmaceuticals (APLS) United States $0.778B 0.00
InflaRx (IFRX) Germany $0.777B 0.00
Arvinas (ARVN) United States $0.770B 0.00
Intra-Cellular Therapies (ITCI) United States $0.765B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.761B 0.00
Heska (HSKA) United States $0.743B 60.84
Cellectis (CLLS) France $0.726B 0.00
Principia Biopharma (PRNB) United States $0.723B 0.00
ANI Pharmaceuticals (ANIP) United States $0.722B 13.81
Dicerna Pharmaceuticals (DRNA) United States $0.718B 0.00
Dynavax Technologies (DVAX) United States $0.698B 0.00
Acorda Therapeutics (ACOR) United States $0.680B 8.83
Cara Therapeutics (CARA) United States $0.670B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.663B 0.00
Revance Therapeutics (RVNC) United States $0.654B 0.00
RA PHARMCTL INC (RARX) United States $0.650B 0.00
Viking Therapeutics (VKTX) United States $0.648B 0.00
Twist Bioscience (TWST) United States $0.643B 0.00
Intellia Therapeutics (NTLA) United States $0.607B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.577B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.567B 0.00
UROGEN PHARMA (URGN) Israel $0.565B 0.00
Kura Oncology (KURA) United States $0.564B 0.00
Eidos Therapeutics (EIDX) United States $0.563B 0.00
Anika Therapeutics (ANIK) United States $0.562B 23.25
Osiris Therapeutics (OSIR) United States $0.550B 0.00
Synthorx (THOR) United States $0.546B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.542B 0.00
Arcus Biosciences (RCUS) United States $0.529B 0.00
Prothena (PRTA) Ireland $0.524B 0.00
Zymeworks (ZYME) Canada $0.502B 0.00
PDL BioPharma (PDLI) United States $0.486B 7.93
UNITY Biotechnology (UBX) $0.476B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.466B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.465B 0.00
Scholar Rock Holding (SRRK) United States $0.462B 0.00
ObsEva SA (OBSV) Switzerland $0.451B 0.00
DBV Technologies (DBVT) France $0.450B 0.00
Zealand Pharma (ZEAL) Denmark $0.450B 4.96
Senesco Technologies (ELOX) United States $0.446B 0.00
Replimune (REPL) United States $0.445B 0.00
Agenus (AGEN) United States $0.433B 0.00
Cytokineticsorporated (CYTK) United States $0.432B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.424B 0.00
Kezar Life Sciences (KZR) United States $0.420B 0.00
Five Prime Therapeutics (FPRX) United States $0.411B 0.00
OSMOTICA PHARM (OSMT) United States $0.406B 0.00
BeyondSpring (BYSI) United States $0.404B 0.00
Mesoblast (MESO) Australia $0.398B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.373B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.369B 0.00
Kindred Biosciences (KIN) United States $0.367B 0.00
Sinovac Biotech (SVA) China $0.367B 0.00
AVROBIO (AVRO) United States $0.367B 0.00
Stemline Therapeutics (STML) United States $0.365B 0.00
Cellular Biomedicine (CBMG) United States $0.360B 0.00
Inovio Pharmaceuticals (INO) United States $0.353B 0.00
MeiraGTx Holdings (MGTX) United States $0.350B 0.00
Gamida Cell (GMDA) Israel $0.339B 0.00
Gritstone Oncology (GRTS) United States $0.337B 0.00
Krystal Biotech (KRYS) United States $0.332B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.330B 0.00
BioDelivery Sciences (BDSI) United States $0.328B 0.00
MediciNova (MNOV) United States $0.322B 0.00
Aduro Biotech (ADRO) United States $0.322B 0.00
Abeona Therapeutics (ABEO) United States $0.318B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
Urovant Sciences (UROV) United States $0.314B 0.00
XBiotech (XBIT) United States $0.310B 0.00
Constellation Pharmaceuticals (CNST) United States $0.308B 0.00
Magenta Therapeutics (MGTA) United States $0.306B 0.00
Evelo Biosciences (EVLO) United States $0.293B 0.00
Enochian BioSciences (ENOB) United States $0.287B 0.00
Sorrento Therapeutics (SRNE) United States $0.285B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.283B 0.00
Solid Biosciences (SLDB) United States $0.283B 0.00
Axsome Therapeutics (AXSM) United States $0.278B 0.00
Geron (GERN) United States $0.274B 0.00
Intec Pharma (NTEC) Israel $0.269B 0.00
AC Immune SA (ACIU) Switzerland $0.261B 0.00
Kadmon Holdings (KDMN) United States $0.259B 0.00
Merus (MRUS) Netherlands $0.258B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.254B 0.00
Kodiak Sciences (KOD) United States $0.252B 0.00
Seres Therapeutics (MCRB) United States $0.250B 0.00
Liquidia Technologies (LQDA) United States $0.247B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.247B 0.00
Kala Pharmaceuticals (KALA) United States $0.244B 0.00
Verastem (VSTM) United States $0.244B 0.00
Celcuity (CELC) United States $0.241B 0.00
Adverum Biotechnologies (ADVM) United States $0.240B 0.00
Synlogic (SYBX) United States $0.236B 0.00
Kamada (KMDA) Israel $0.236B 10.64
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
MannKind (MNKD) United States $0.231B 0.00
Syros Pharmaceuticals (SYRS) United States $0.231B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.225B 0.00
ResTORbio (TORC) United States $0.225B 0.00
Strongbridge Biopharma (SBBP) United States $0.221B 0.00
TOCAGEN INC (TOCA) United States $0.219B 0.00
Athersys (ATHX) United States $0.217B 0.00
Arbutus Biopharma (ABUS) Canada $0.215B 0.00
LogicBio Therapeutics (LOGC) United States $0.209B 0.00
ChromaDex (CDXC) United States $0.208B 0.00
Cerecor (CERC) United States $0.207B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.204B 0.00
Celyad SA (CYAD) Belgium $0.201B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.196B 0.00
Aptinyx (APTX) United States $0.189B 0.00
Compugen (CGEN) Israel $0.186B 0.00
Axovant Sciences (AXGT) United Kingdom $0.185B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
Protagonist Therapeutics (PTGX) United States $0.178B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.174B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.166B 0.00
Enzo Biochem (ENZ) United States $0.166B 0.00
Menlo Therapeutics (MNLO) United States $0.164B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.159B 0.00
VBI Vaccines (VBIV) United States $0.157B 0.00
Mersana Therapeutics (MRSN) United States $0.156B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.155B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.151B 0.00
Proteostasis Therapeutics (PTI) United States $0.149B 0.00
OvaScience (MLND) United States $0.145B 0.00
Allena Pharmaceuticals (ALNA) United States $0.143B 0.00
Cohbar (CWBR) United States $0.137B 0.00
BioXcel Therapeutics (BTAI) United States $0.136B 0.00
Cue Biopharma (CUE) United States $0.134B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.133B 0.00
Unum Therapeutics (UMRX) United States $0.129B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Trevena (TRVN) United States $0.127B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
Fortress Biotech (FBIO) United States $0.124B 0.00
Mustang Bio (MBIO) United States $0.122B 0.00
Anavex Life Sciences (AVXL) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.121B 0.00
Checkpoint Therapeutics (CKPT) United States $0.121B 0.00
Pluristem Therapeutics (PSTI) Israel $0.119B 0.00
Eton Pharmaceuticals (ETON) United States $0.119B 0.00
XOMA (XOMA) United States $0.118B 0.00
Equillium (EQ) United States $0.113B 0.00
Catalyst Biosciences (CBIO) United States $0.107B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
VTv Therapeutics (VTVT) United States $0.097B 0.00
Chiasma (CHMA) United States $0.095B 0.00
Neothetics (EVFM) United States $0.093B 0.00
Signal Genetics (MGEN) United States $0.091B 0.00
NantKwest (NK) United States $0.090B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.082B 0.00
Cocrystal Pharma (COCP) United States $0.079B 88.33
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.078B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.077B 0.00
Alimera Sciences (ALIM) United States $0.076B 0.00
Provention Bio (PRVB) United States $0.075B 0.00
PHASEBIO PHARMA (PHAS) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Aptose Biosciences (APTO) Canada $0.072B 0.00
INMUNE BIO INC (INMB) United States $0.070B 0.00
Cidara Therapeutics (CDTX) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Celldex Therapeutics (CLDX) United States $0.067B 0.00
SESEN BIO, INC (SESN) United States $0.065B 0.00
AEterna Zentaris (AEZS) United States $0.065B 12.28
Sienna Biopharmaceuticals (SNNA) United States $0.062B 0.00
OVID THERAPEUTC (OVID) United States $0.062B 0.00
Prima BioMed (IMMP) Australia $0.060B 0.00
Applied Genetic Technologies (AGTC) United States $0.059B 0.00
Evogene (EVGN) Israel $0.058B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.058B 0.00
Ophthotech (OPHT) United States $0.058B 0.00
Proteon Therapeutics (PRTO) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
Eyenovia (EYEN) United States $0.056B 0.00
Entera Bio (ENTX) Israel $0.054B 0.00
VIVUS (VVUS) United States $0.054B 0.00
ScPharmaceuticals (SCPH) United States $0.053B 0.00
ARAVIVE, INC (ARAV) United States $0.053B 4.67
Alcobra (ARCT) United States $0.053B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.045B 0.00
Selecta Biosciences (SELB) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Celsion (CLSN) United States $0.041B 0.00
Caladrius Biosciences (CLBS) United States $0.041B 0.00
OncoSec Medical (ONCS) United States $0.041B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Motif Bio Plc (MTFB) United States $0.040B 0.00
Arsanis (ASNS) United States $0.039B 0.00
DiaMedica Therapeutics (DMAC) United States $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.037B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.034B 5.58
Curis (CRIS) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
Galena Biopharma (SLS) United States $0.031B 0.00
AZURRX BIOPHARM (AZRX) United States $0.031B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.031B 0.00
Adial Pharmaceuticals (ADIL) United States $0.030B 0.00
TRACON Pharmaceuticals (TCON) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.028B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Advaxis (ADXS) United States $0.028B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
GENPREX INC (GNPX) United States $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
GTx (GTXI) United States $0.023B 0.00
Vical (VICL) United States $0.022B 0.00
CytRx (CYTR) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.020B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Soligenix (SNGX) United States $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 7.25
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Neuralstem (CUR) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
RestorGenex (DFFN) United States $0.008B 0.00
Histogenics (HSGX) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00